“We only apply AM when and where it makes sense, never just for the sake of it.” As far as AM mantras go, this one is pretty hard to beat. The team at Sartorius knows that finding the right application is essential, especially in an industry as highly regulated as biotech. From testing different materials to evaluating technologies before committing to design, their story is full of helpful lessons. https://mtls.am/4dx4Td8
Materialise Manufacturing’s Post
More Relevant Posts
-
Get an insider's look at the quality controls and regulatory expertise that set us apart! #Biotech #Biopharma #LifeSciences #Pharmaceuticals #Biotechnology #PharmaManufacturing #DrugDevelopment #RegulatoryAffairs #QualityControl
New treatment modalities bring life-changing medicines to those in need, but they also create scale-up and manufacturing challenges. Keeping up with demand requires new technology expertise, skillsets, and processes. Learn more about the quality controls and regulatory expertise we bring to the table to give our customers the edge from our EVP of Bioscience Production, Benoit Gourdier, and VP Commercial & GM of Bioscience Production AMEA, Narayana Rao R.
-
Collaborations like this are a prime example of how Pearland connects our companies to education partners to address there needs. Check out the full article below!
A collaboration between Lonza and Alvin Community College is addressing the growing talent demand while advancing Houston's biotech industry. 🧬Read more: https://ow.ly/9OLo50SN9b1
-
-
Global scale bioproduction requires both a broad infrastructure and a deep understanding of local regulatory requirements to maximize outputs. At Avantor our teams support biomanufacturing working with customers in over 180 countries across three continents, helping to find the right solutions that enable them to get to market faster
New treatment modalities bring life-changing medicines to those in need, but they also create scale-up and manufacturing challenges. Keeping up with demand requires new technology expertise, skillsets, and processes. Learn more about the quality controls and regulatory expertise we bring to the table to give our customers the edge from our EVP of Bioscience Production, Benoit Gourdier, and VP Commercial & GM of Bioscience Production AMEA, Narayana Rao R.
-
As new therapies move from research and development to commercialization, improving yields while upholding rigorous quality and regulatory standards is critical. Discover how we’re applying our operational expertise to help customers address scale-up and manufacturing challenges and bring innovative medicines to patients. Listen to our EVP of Bioscience Production, Benoit Gourdier, and VP Commercial & GM of Bioscience Production AMEA, Narayana Rao R, as they explain how our quality controls and regulatory expertise give customers a competitive edge. #AvantorSetsScienceInMotion
New treatment modalities bring life-changing medicines to those in need, but they also create scale-up and manufacturing challenges. Keeping up with demand requires new technology expertise, skillsets, and processes. Learn more about the quality controls and regulatory expertise we bring to the table to give our customers the edge from our EVP of Bioscience Production, Benoit Gourdier, and VP Commercial & GM of Bioscience Production AMEA, Narayana Rao R.
-
🎉 Exciting News! We are thrilled to announce that Altorfer Engineering GmbH has joined the Swiss Biotech Association! 🚀 As we are in a start-up mode, being part of the Swiss Biotech Association is critical to fostering innovation, collaboration, and advancement within the biotech industry. Altorfer Engineering GmbH's expertise in aseptic drug process development, technology transfer and commitment to execution excellence will undoubtedly contribute to the innovative ecosystem of the Swiss Biotech community. 💡 While the biotech communities continue to push the boundaries of science and technology, this membership shall make process development and technology transfer expertise more accessible to the communities that are getting ready for clinical or commercial manufacturing. We aim to accelerate your molecule to market time and improve healthcare by providing aseptic processing and engineering expertise to move your innovation to the next level. #Biotech #Innovation #Collaboration #SwissBiotechAssociation #AltorferEngineering #Aseptic #DrugProduct #Vaccines https://lnkd.in/dPpjTcBZ
-
Read our recent whitepaper, "The Stage-Gate Model: A Value-Driven Approach to Accelerate Biomanufacturing" to gain insight into creating a suitable tech transfer process for both early and late-stage programs. Learn more: https://hubs.ly/Q02hyPsZ0 #biomanufacturing #techtransfer #processdevelopment #analyticaldevelopment #resilience
The Stage-Gate Model: A Proven Approach to Streamline Biomanufacturing
resilience.com
-
Discover more about Serán’s science-first, technology driven approach to drug development and drug product design. Our Principal Engineer, Wesley Tatum, Ph.D, sat down with PharmTech to discuss what makes Serán's approach to formulation development a differentiator in our customer's success. Tune in to learn: ⌚ How Serán uses materials science experience to evaluate each project's compound limitations and timelines to establish a lead formulation early in Ph1 🤝How Serán’s partnership philosophy means we will actively work alongside you to meet project goals and timelines. 📏 How Serán applies a client-centric, scalable and flexible formulation design that supports your program as it advances Learn more and watch the interview: https://hubs.li/Q02gvd060
Insights from a Principal Engineer - Serán Bioscience
-
In this interview with QPS Holdings, LLC Study Director, Polung Yang, we explore the evolution and innovation of automated procedures in primary cell procurement and delivery. Discover the potential to reshape research, manufacturing and clinical trials >>> https://hubs.ly/Q02HplwB0
Innovative new Leukopak facility at QPS: an interview with Polung Yang
